Research Capital Corporation – Additional Phase 2a Analysis by a Chronic Cough KOL

We are maintaining our SPECULATIVE BUY rating & C$25 Target Price.
Dr Jacky Smith is a key opinion leader (KOL) in chronic cough. An additional statistical analysis of Algernon’s Phase 2a data in IPF patients with chronic cough confirmed Dr. Smith’s original positive impression of the study.

Additional Positive Phase 2a Cough Data – Analyzed by Dr. Jacky Smith

Dr. Jacky Smith, Professor of Respiratory Medicine at the University of Manchester, and an Honorary Consultant at Manchester University NHS Foundation Trust reviewed the Algernon Phase 2a data in IPF patients with chronic cough. Dr Jacky Smith is an expert in chronic cough. As an example, Dr. Smith has been…

Read the full article here: Research Capital Corporation July 28-2022

 

Share via
Copy link
Powered by Social Snap